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Abstract
Background: Translation in axons is required for growth cone chemotropic responses to many
guidance cues. Although locally synthesized proteins are beginning to be identified, how specific
mRNAs are selected for translation remains unclear. Control of poly(A) tail length by cytoplasmic
polyadenylation element (CPE) binding protein 1 (CPEB1) is a conserved mechanism for mRNA-
specific translational regulation that could be involved in regulating translation in axons.
Results: We show that cytoplasmic polyadenylation is required in Xenopus retinal ganglion cell
(RGC) growth cones for translation-dependent, but not translation-independent, chemotropic
responses  in vitro, and that inhibition of CPE binding through dominant-negative interference
severely reduces axon outgrowth in vivo. CPEB1 mRNA transcripts are present at low levels in
RGCs but, surprisingly, CPEB1 protein was not detected in eye or brain tissue, and CPEB1 loss-of-
function does not affect chemotropic responses or pathfinding in vivo. UV cross-linking experiments
suggest that CPE-binding proteins other than CPEB1 in the retina regulate retinal axon
development.
Conclusion:  These results indicate that cytoplasmic polyadenylation and CPE-mediated
translational regulation are involved in retinal axon development, but that CPEB1 may not be the
key regulator of polyadenylation in the developing retina.
Background
The assembly of functional neural circuits in the develop-
ing nervous system requires axonal growth cones to
respond appropriately to guidance cues to lead axons to
their correct targets [1]. Growth cone chemotropic
responses to many guidance cues require local axonal
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translation and induce global translation activation [2-5].
However, axons are estimated to contain approximately
100–200 mRNAs [6,7], and guidance cues do not induce
the translation of all of them. Indeed, guidance cues that
have different effects on growth cones induce translation
of different proteins, such as β-actin or CREB (cAMP
response element binding protein) for some attractive
cues [8-10] versus RhoA or cofilin for some repulsive cues
[4,11]. RNA-binding proteins regulating axonal mRNAs
are starting to be identified [8,9,12,13] but, overall, the
mechanisms underlying mRNA-specific regulation of
local axonal translation remain unclear.
Control of poly(A) tail length is an attractive candidate
mechanism for mRNA-specific regulation of axonal trans-
lation. With a few exceptions (for example, core histones),
the efficiency of translation of an mRNA depends on the
length of its poly(A) tail. Poly(A) binding protein (PABP),
together with the cap binding factor eukaryotic initiation
factor 4E (eIF4E), helps recruit eIF4G, which indirectly
binds the 40S ribosomal subunit to the 5' end of the
mRNA, thereby stimulating initiation [14-17]. Specific
sequence elements in some mRNAs recruit RNA-binding
proteins that control poly(A) tail length, allowing mRNA-
specific translational regulation by cytoplasmic polyade-
nylation.
The most well-understood mechanism for controlling
cytoplasmic polyadenylation is regulation of mRNAs con-
taining the cytoplasmic polyadenylation element (CPE;
consensus UUUUUAU) by CPE-binding protein (CPEB)1.
According to current models [18], CPEB1 binds to CPE-
containing mRNA and associates with a large complex of
proteins, including the scaffolding protein Symplekin
[19] and cleavage and polyadenylation specificity factor
(CPSF) [20,21]. CPEB1 also binds to a poly(A)-specific
ribonuclease (PARN) and the atypical poly(A) polymer-
ase Gld2 (Germ-line development factor 2), which are
responsible for deadenylating and polyadenylating
CPEB1 target mRNAs, respectively [19,22]. PARN is the
more active enzyme, so when both PARN and Gld2 are
present, the poly(A) tail remains short and the mRNA is
silenced [22]. Phosphorylation of CPEB1 by the kinase
Eg2/Aurora A [23] induces the dissociation of PARN from
the CPEB1-containing complex, allowing Gld2 to elon-
gate the poly(A) tail [22], leading to polyadenylation-
induced translational activation. Other RNA-binding pro-
teins, such as Musashi [24] and Nanos and Pumilio [25],
have also been implicated in regulating cytoplasmic poly-
adenylation, but their mechanisms of action remain
unknown.
Although CPEB1 was first discovered in the maturation of
Xenopus  oocytes [26], it has since been implicated in
diverse functions ranging from cell cycle control [27] to
cell senescence [28]. In addition, CPEB1 regulates local
translation in dendrites [18], a system that, like axonal
translation, allows distal outposts of the neuron to
respond quasi-autonomously to local stimuli [5]. CPEB1
regulates dendritic localization, polyadenylation, and
translation of CPE-containing mRNAs such as CaMKIIα
(Ca2+-calmodulin-dependent protein kinase II α) [29,30].
N-methyl D-aspartate (NMDA) receptor signaling induces
both phosphorylation of CPEB1 via Aurora A kinase and
polyadenylation of CaMKII mRNA at synapses [31], and
induces translation of CPE-containing mRNAs in a polya-
denylation-dependent manner [32]. CPEB1 knockout
mice have subtle defects in learning and memory, show-
ing reduced fear extinction [33] and in certain forms of
long-term potentiation [34]. Overexpression of domi-
nant-negative CPEB1 can cause defects in cerebellar long-
term depression and motor learning [35] or dendritic
arborization [36].
The function of cytoplasmic polyadenylation in diverse
systems from Xenopus oocyte maturation to synaptic plas-
ticity suggested that this might be a conserved mechanism
for translational regulation in neurons and, therefore, a
good candidate for regulating translation in axonal
growth cones. Therefore, we asked whether cytoplasmic
polyadenylation and CPEB1 might play a role in regulat-
ing translation for growth cone chemotropic responses.
We found that translation-dependent, but not translation-
independent, growth cone chemotropic responses require
cytoplasmic polyadenylation. CPEB1 protein, however, is
not detected in the retina and CPEB1 loss-of-function
does not cause retinal axon guidance defects. UV cross-
linking experiments show that other CPE-binding pro-
teins are present in the retina and, indeed, dominant-neg-
ative inhibition of CPE-binding causes defects in axon
outgrowth. Together, these results suggest that both cyto-
plasmic polyadenylation and CPE-mediated translational
regulation are important for retinal ganglion cell (RGC)
axon growth and guidance.
Results
Inhibition of polyadenylation blocks Semaphorin3A-
induced growth cone collapse
Bath application of Semaphorin3A (Sema3A) causes
Xenopus RGC growth cones to collapse, that is, to lose their
filopodia and lamellipodia and assume a thin, non-
motile form [37]. Sema3A-induced growth cone collapse
occurs maximally at 10 minutes and requires local protein
synthesis [2,11]. To address whether Sema3A-induced
collapse requires cytoplasmic polyadenylation, we used
the polyadenylation inhibitor 3'deoxyadenosine (cordyc-
epin). When converted to cordycepin 5'triphosphate
(3'dATP), it inhibits polyadenylation [38] by acting as a
chain terminator due to the lack of a 3' hydroxyl group.
Cordycepin, which does not affect protein kinase activity,Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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inhibits cytoplasmic polyadenylation and meiotic matu-
ration in Xenopus  oocytes [39,40] and CPE-mediated
translational activation in hippocampal neurons [32]. We
incubated cultures with 200 μM cordycepin for 30 min-
utes to allow the cordycepin to enter the growth cone and
be converted to cordycepin triphosphate to be added to
poly(A) tails as a chain terminator, and then treated the
cultures with Sema3A for 10 minutes.
We found that cordycepin, but not adenosine, completely
abolished Sema3A-induced growth cone collapse (Figure
1A, B). In contrast, cordycepin had no effect on growth
cone collapse in response to lysophosphatidic acid,
another repulsive cue that does not require protein syn-
thesis for its effects [2] (Figure 1C). This result indicates
that cordycepin does not have non-specific toxic effects on
growth cone responsiveness or collapsing capability.
To rule out effects of cordycepin on the cell body, we sev-
ered axons from their cell bodies before treating them
with cordycepin and Sema3A. Again, cordycepin blocked
Sema3A-induced collapse but not lysophosphatidic acid-
induced collapse (Figure 1D, E). This result implies that
cytoplasmic, not nuclear, polyadenylation is required for
collapse.
We used two methods to exclude the possibility that
cordycepin abolishes translation of all mRNAs. First, we
labeled newly synthesized proteins in Sema3A-stimulated
and control retinal cultures with puromycin, a chain-ter-
minating tRNA analogue that tags the carboxyl terminus
of nascent proteins [41,42]. At the concentrations used in
this study (0.5–2 μM), puromycin can label all nascent
proteins, both full-length and incomplete, which pro-
duces an indistinct 'smear' of puromycin labeling when
labeled proteins are separated by SDS-PAGE and detected
by anti-puromycin western blot (Figure 1F). Puromycin
labeling is abolished by the peptidyl transferase inhibitor
anisomycin (Figure 1F). Note that the distinct bands (as
opposed to the 'smear') in Figure 1F, G are from non-spe-
cific binding by the anti-puromycin antibody, because the
same bands also appear on samples incubated with the
peptidyl transferase inhibitor anisomycin (Figure 1F) and
on samples not incubated with puromycin (data not
shown). Sema3A stimulation causes an increase in puro-
mycin incorporation; this increase is slightly reduced, but
not abolished, by cordycepin (Figure 1F, G). Because
puromycin labels the mixture of full-length and incom-
plete proteins, this slight reduction in puromycin incor-
poration could represent either a reduction in overall
protein synthesis or the blockade of synthesis of specific
proteins.
Second, we tested the effect of cordycepin on basal trans-
lation rates in A6 cells, a Xenopus kidney cell line. We incu-
bated A6 cells with 3H-leucine for 5 minutes and
measured the incorporation of 3H-leucine into trichloro-
acetic acid-insoluble material by scintillation counting.
Cordycepin pre-treatment had no effect on incorporation
of  3H-leucine, while the protein synthesis inhibitor
cycloheximide almost completely abolished it (Figure
1H). Together with the puromycin experiment, these
results suggest that cordycepin is not a general translation
inhibitor under these conditions and, thus, most likely
exerts its effects through blocking polyadenylation.
CPEB1 mRNA is expressed at low levels in the embryonic 
retina
Given that cytoplasmic polyadenylation is required for
growth cone collapse, we considered the mechanisms by
which cytoplasmic polyadenylation could be regulated in
growth cones. CPEB1 was a good candidate for playing a
central role in this process for several reasons. First, CPEB1
regulates translation via cytoplasmic polyadenylation in
several systems, from Xenopus oocytes to both mamma-
lian and invertebrate neurons. Second, CPEB1 is by far the
most well-characterized regulator of cytoplasmic polyade-
nylation and has been especially well-studied in Xenopus.
Finally, according to large-scale in situ hybridization stud-
ies, the mouse and zebrafish homologs of CPEB1 (known
as zorba in zebrafish) are expressed in the embryonic ret-
ina [43,44].
Given the conserved role of CPEB1 in regulating transla-
tion via cytoplasmic polyadenylation in systems ranging
from  Xenopus  oocytes to mammalian and invertebrate
neurons, we asked whether CPEB1 is expressed in Xenopus
RGCs. We found by RT-PCR and wholemount in situ
hybridization that CPEB1 mRNA is expressed in Xenopus
stage 35/36 and stage 41 eyes (Figure 2A–C). CPEB1 is
also expressed in the nasal placodes and in a segmented
pattern in the dorsal spinal cord and weakly in the brain
(Figure 2B, C; data not shown). The first pioneer RGC
axons grow through the optic tract at stage 35/36, arriving
in the tectum at stage 37/38 and arborizing at stage 39
[45], but because RGCs are born from stage 25 through
stage 33/34–35/36 [46-48], many later-born RGC axons
are still navigating through the optic tract at stage 41.
Thus, CPEB1 is expressed at the right time and place to
play a role in axon guidance. It should be noted, however,
that the CPEB1 signal detected by in situ hybridization in
the eye and brain is weak when compared to the robust
signal in other areas such as the nasal placodes and spinal
cord (Figure 2B, C). To address whether CPEB1 is present
in RGCs, in situ stained wholemount embryos (Figure 2B,
C) were sectioned but the in situ signal was too faint to be
clearly seen in the thin tissue, although the RGC layer did
not exhibit an obvious lack of signal relative to the other
layers (data not shown). Therefore, to confirm that CPEB1
is expressed specifically in RGCs, we used laser captureNeural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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Cytoplasmic polyadenylation is required for growth cone collapse Figure 1
Cytoplasmic polyadenylation is required for growth cone collapse. (A) Typical examples of collapsed and non-col-
lapsed growth cones. (B) Cordycepin (200 μM; 3'deoxyadenosine; Cordy), but not adenosine (Adeno), blocks Sema3A-
induced growth cone collapse. (C) Cordycepin does not affect lysophosphatidic acid (LPA)-induced growth cone collapse. (D, 
E) Similar results are obtained as in (B, C) if axons are severed from their cell bodies. (F, G) Anti-puromycin western blots on 
stage 35/36 retinal cultures incubated for 15 minutes with 2 μM puromycin and 50 μM LnLL (F) or 0.5 μM puromycin (G), ± 2 
μg/ml Sema3A-Fc, ± 40 μM anisomycin (aniso), ± 200 μM cordycepin or adenosine. Cordycepin slightly reduces, but does not 
abolish, Sema3A-induced translation (G); see text for details. The two separate sections in (F) are from the same blot with the 
same film exposure and contrast settings. (H) Cordycepin does not block basal translation in A6 fibroblasts, while cyclohex-
imide (CHX) does. Numbers in bars indicate number of growth cones counted. *p < 0.05, **p < 0.01, ***p < 0.001. Error bars 
represent standard error of the mean.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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microdissection to extract RNA specifically from the RGC
layer of stage 41 eyes (Figure 2D), using this stage because
the retina is not fully laminated at stage 35/36. This tech-
nique excludes other retinal layers, although we cannot
completely exclude the presence of mRNAs from non-
RGC neuroepithelial or glial cells whose endfeet reside in
the RGC layer. RT-PCR showed that CPEB1 mRNA is
present in stage 41 RGCs (Figure 2E).
The other members of the CPEB family, CPEB2–4, are also
expressed in stage 35/36 and stage 41 eyes (Figure 2F), but
because there is no evidence that these proteins control
cytoplasmic polyadenylation [49], we focused our atten-
tion on CPEB1.
CPEB1 loss-of-function does not cause defects in retinal 
axon pathfinding
We next asked whether knocking down CPEB1 function
would affect growth cone chemotropic responses and
axon guidance, using antisense morpholino oligonucle-
otides, which effectively and specifically block translation
of target mRNAs [50,51]. A carboxyfluorescein-tagged
antisense morpholino (MO) directed against the ATG
start site of CPEB1 mRNA successfully blocked translation
of CPEB1-RBM-GFP mRNA (CPEB1-RNA binding mutant
-green fluorescent protein; see below) when 20 ng MO
and 2 ng mRNA per embryo were co-injected into blast-
omeres at the two-cell stage (Figure 3A). Retinal axons cul-
tured from injected embryos contained
carboxyfluorescein-tagged MO (Figure 3B). Surprisingly,
blastomere injection of CPEB1 MO did not affect
Sema3A-induced growth cone collapse (Figure 3C). To
avoid the possibility that the CPEB1 MO may not be effec-
tive 80 hours after injection [50], we electroporated the
CPEB1 MO into the eye at stage 28 (32 hours post-fertili-
zation), which labeled retinal cell bodies (Figure 3D) and
growth cones (Figure 3E). Again, the CPEB1 MO did not
affect Sema3A-induced growth cone collapse (Figure 3E).
Consistent with this, blastomere injection of 20 ng CPEB1
MO per embryo had no obvious effect on axon pathfind-
ing through stage 41 in vivo, as assessed by DiI labeling
(Figure 3F).
Similarly, the CPEB1 knockout mouse [52] does not have
obvious retinal axon guidance defects. We assessed intra-
retinal guidance by staining wholemount retinas for beta-
tubulin, and overall retinal axon pathfinding by labeling
RGC axons with DiI, in embryonic day (E)17–E19 mouse
embryos. No obvious differences were seen between
CPEB1 knockout mice and heterozygous littermates (Fig-
ure 3H, F). Consistent with this, aside from subtle defects
in learning and memory, the CPEB1 knockout mouse
does not have obvious behavioral, motor, or sensory
defects [33,34], as might be expected if axon pathfinding
were perturbed.
Xenopus embryonic retinas express multiple CPE-binding 
proteins
To confirm that the CPEB1 MO affected translation of
endogenous CPEB1 mRNA, we performed western blots
of stage 41 retinas using two antibodies against Xenopus
CPEB1 (labeled as 'pc' and 'pept' in Figure 4A) and one
against human CPEB1 ('2B7'), each directed against dif-
ferent epitopes in CPEB1 (see Materials and methods).
Despite the expression of CPEB1 mRNA (Figure 2),
CPEB1 protein was not detectable by western blot in
embryonic eyes at stage 35/36, 41, and 45, or in stage 45
heads (Figure 4A), although all three antibodies detect
Xenopus CPEB1 in stage VI oocytes (Figure 4A) and recom-
binant CPEB1-RBM-GFP expressed in embryos by blast-
omere injection of CPEB1-RBM-GFP mRNA (Figure 4B).
The 2B7 monoclonal anti-CPEB1 antibody detects a band
in embryonic tissue 2–3 kDa smaller than the CPEB1 in
oocytes, but this is most likely non-specific binding, as
neither of the other two antibodies recognizes it. We also
tested a commercially available antibody against human
CPEB1 that reportedly detects CPEB1 in Xenopus larval
brains [36]. Using the same western blot methods as that
study, we found that this antibody detected multiple non-
specific bands and none could be identified as CPEB1 in
embryonic eyes and brains up to stage 48 or even in
oocytes (data not shown). We also did not detect CPEB1
in stage 48 brains using the two anti-Xenopus CPEB1 anti-
bodies ('pc' and 'pept'; data not shown). Although these
results do not exclude the possibility of very low levels of
CPEB1 protein in the retina (see Discussion), they do call
into question what function such a minute amount of
CPEB1 could have. Other proteins in the CPEB1 complex,
such as Symplekin, Gld2, and PARN, are present in the ret-
ina, but seem to be mainly localized to the nucleus in
RGCs (Additional file 1).
However, given that developing embryos may use differ-
ent translational regulators to perform similar functions at
different times [53], we hypothesized that other proteins
may assume the role of CPEB1 in regulating CPE-contain-
ing mRNAs in embryos. Therefore, we asked whether
there are other CPE-binding proteins in the retina using
UV cross-linking. We incubated stage 41 eye extracts with
32P-labeled probes consisting of the 3' untranslated region
(UTR) of Xenopus cyclin B1, with its CPE motifs intact or
mutated. After UV cross-linking, the proteins were
resolved by SDS-PAGE; two bands, at approximately 60
kDa and approximately 95 kDa, were bound to the CPE
probe but not the mutated probe (Figure 4C). Although
CPEB1 is approximately 60 kDa, the 60 kDa CPE-binding
protein we detected is most likely not CPEB1, because
western blots with anti-CPEB1 antibodies did not detect
the 60 kDa 32P-labeled band, and because immunoprecip-
itation with anti-CPEB1 did not precipitate any 32P-Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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CPEB1 mRNA is expressed in the Xenopus embryonic retina Figure 2
CPEB1 mRNA is expressed in the Xenopus embryonic retina. (A) RT-PCR shows that CPEB1 is expressed in stage 
35/36 and stage 41 eyes and that the level of expression is higher at stage 41. (B, C) Wholemount in situ hybridization on stage 
35/36 (B) and stage 41 (C) embryos shows that CPEB1 is weakly expressed in the eyes, as well as the nasal placode and brain, 
and in a segmented pattern in the dorsal spinal cord. The sense probe gives no signal. AS, antisense; np, nasal placode; S, sense; 
sc, spinal cord. (D) Section of stage 41 eye before (D) and after (D') laser capture microdissection of the retinal ganglion cell 
layer. Abbreviations: inl, inner nuclear layer; le, lens; onl, outer nuclear layer; rgc, retinal ganglion cell layer; rpe, retinal pigment 
epithelium. (E) RT-PCR on RNA from the retinal ganglion cell layer isolated by laser capture microdissection shows that 
CPEB1 is expressed in retinal ganglion cells. (F) CPEB2–4 are also expressed in embryonic eyes and brains by RT-PCR.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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CPEB1 loss-of-function does not cause obvious retinal axon guidance defects Figure 3
CPEB1 loss-of-function does not cause obvious retinal axon guidance defects. (A) Anti-green fluorescent protein 
(GFP) western blot on lysates of stage 24 embryos injected with 1 ng CPEB1-RBM-GFP mRNA with or without CPEB1 mor-
pholino (MO) at the two-cell stage. CPEB1 MO effectively knocks down expression of CPEB1-GFP. (B) DiI filling of the retinal 
projection of stage 41 Xenopus embryos injected with CPEB1 MO at the two-cell stage shows no obvious defect in in vivo axon 
pathfinding. Uninj, uninjected. (C-G) Blastomere injection (C-D) and electroporation (EP) (E-G) of CPEB1 MO does not affect 
Sema3A-induced growth cone collapse. Blastomere injection (C) and electroporation (E, F) of carboxyfluorescein-tagged 
CPEB1 MO labels cell bodies (E) and growth cones (C, G) containing the MO with green fluorescence. (H) Beta-tubulin stain-
ing of wholemount mouse retinas shows no obvious defect in intraretinal guidance in embryonic day (E)18 CPEB1 knockout 
mice; retinal axons converge normally on the optic disc. (I, J) DiI filling of the retinal projection at E18–19 reveals no obvious 
defect in retinal axon guidance at the optic chiasm (F) or in the optic tract (G). Abbreviations: ch, optic chiasm; dLGN, dorsal 
lateral geniculate nucleus; sc, superior colliculus. Error bars represent standard error of the mean.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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labeled probe. These results indicate that at least two pro-
teins in the retina bind specifically to CPE sequences.
Interfering with endogenous CPE-binding proteins impairs 
axon outgrowth
Given the presence of CPE-binding proteins in the retina,
we addressed the role they might play in retinal axon
guidance. Because the short length of the CPE sequence
makes it impractical to block CPE-binding using CPE anti-
sense oligonucleotides, we competitively interfered with
the function of CPE-binding proteins using CPEB1
mutants. One mutant, CPEB1-AA, has two serine residues
(S174 and S180) mutated to alanines, so that it cannot
undergo the phosphorylation critical for activating the
translation of its target mRNAs in other systems like Xeno-
pus  oocytes [23]. CPEB1-AA would compete with the
endogenous CPE-binding proteins for CPE motifs, and
mRNAs with CPEs would be mis-regulated by being
bound by CPEB1 rather than their natural CPE-binding
proteins (Figure 5C); thus, CPEB1-AA acts as a dominant
negative in inhibiting CPE-mediated mRNA regulation.
Overexpression of CPEB1-AA prevents oocyte maturation
[23] and cerebellar long-term depression and motor
learning [35]. For a negative control, we used a CPEB1
mutant defective in RNA binding (CPEB1-RNA binding
mutant, or RBM) with point mutations (C529A, C539A)
in the zinc-finger domain that abolish its binding to CPE-
containing RNAs [54], in order to control for non-specific
effects of CPEB1 overexpression unrelated to its RNA
binding capability (Figure 5B). GFP was fused to the car-
boxyl terminus of these constructs [30] to allow visualiza-
tion of transfected cells and axons, and the constructs
were electroporated into the retina at stage 28 [55].
We first asked whether CPEB1-AA-GFP (hereafter AA)
would affect retinal axon guidance in vitro. Retinal explant
cultures from AA-transfected eyes did not yield any GFP-
positive axons, even though GFP signal was visible in the
explant; this lack of axon outgrowth prevented us from
testing whether CPEB1-AA prevents Sema3A-mediated
collapse. To test whether AA-transfected RGCs form axons
that are too short to exit the explant, we performed disso-
ciated retinal cell culture using eyes with AA or CPEB1-
RBM-GFP (hereafter RBM). AA-transfected cells had a
reduced rate of neurite formation compared to RBM-
transfected cells (Figure 5D), and the neurites that did
form were significantly shorter (Figure 5E–G). In prelimi-
nary experiments, a similar inhibition of neurite out-
growth was also observed in cells transfected with wild-
type CPEB1 (data not shown). These results suggest that
disruption of CPE-mediated mRNA regulation by CPEB1-
AA causes defects in neurite outgrowth.
Because dissociated retinal cell cultures contain other cell
types aside from RGCs, we sought to extend these findings
to RGC axon outgrowth in vivo by allowing embryos elec-
troporated at stage 28 to grow to stage 41, at which point
RGC axons have normally arrived in the tectum and
begun branching. RBM-transfected RGCs extended GFP-
positive axons correctly to the contralateral optic tectum
(Figure 6A). In contrast, no GFP-positive axons were ever
seen in the contralateral brain in AA-transfected embryos
(0 of 22 brains; Figure 6B), although expression of the
construct in RGCs was confirmed by sectioning the elec-
troporated eye or cutting it in half and mounting it (data
not shown). This effect was cell-autonomous because co-
electroporation of AA and membrane-tagged red fluores-
cent protein (GAP-RFP) plasmids yielded many RFP-pos-
itive, but no GFP-positive, axons navigating correctly to
the tectum (data not shown). However, CPEB1-GFP tends
to form large discrete puncta in neurites in vitro (Figure
3D) [30] and an axon containing only sparse GFP puncta
might be difficult to identify as an axon in vivo.
We sought to confirm that the lack of axons growing into
the brain was not simply due to detection failure by co-
transfecting cells with GAP-RFP, ensuring co-expression
using a bidirectional plasmid in which CPEB1-GFP is
driven by the cytomegalovirus promoter and GAP-RFP is
driven by the mouse phosphoglycerate kinase (PGK) pro-
moter (Figure 6C). These constructs were well-expressed
in electroporated eyes (Figure 6D–G). Both RBM- and AA-
transfected embryos had bright RFP-positive axons in the
optic nerve head, where RFP signal colocalized with dis-
crete CPEB1-GFP puncta in AA-transfected embryos and
more diffuse CPEB1-GFP in RBM-transfected embryos
(Figure 6I). However, in cryosections, such RFP- and GFP-
positive axons never extended into the optic tract and only
rarely reached the optic chiasm in AA-transfected
embryos, whereas they almost always reached the optic
tectum in RBM-transfected embryos (Figure 6H–L). In
wholemount preparations, RBM-transfected, but not AA-
transfected, embryos had bright RFP-positive axons in the
contralateral brain (Figure 6M, N). Extremely faint RFP-
positive axons could be detected in AA-transfected
embryos using a high-sensitivity camera (Additional file
2B), but these never contained CPEB1-GFP and were
much dimmer than the RFP-positive axons in the contral-
ateral brain of RBM-transfected embryos (Additional file
2A–C). In contrast, the RFP-positive axons in the optic
nerve head and optic nerve often contained CPEB1-GFP
and were of similar brightness in RBM- and AA-trans-
fected embryos (Figure 7H; Additional file 2D). Because
electroporation introduces random amounts of plasmid
into transfected cells, this contrast suggests that of the
population of AA-transfected RGCs, only those receiving
extremely small amounts of plasmid are able to extend
axons into the brain, as they do not express enough
CPEB1-AA to have any effect but express just enough GAP-
RFP to be visible. Similar defects in axon outgrowth ofNeural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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Xenopus embryonic retinas contain non-CPEB1 cytoplasmic polyadenylation element (CPE)-binding proteins Figure 4
Xenopus embryonic retinas contain non-CPEB1 cytoplasmic polyadenylation element (CPE)-binding proteins. 
(A) Western blots using three different antibodies do not detect CPEB1 protein in stage 45 eyes, stage 45 heads, stage 41 
eyes, or stage 35/6 eyes. However, they do detect CPEB1 in stage VI oocytes. pc, polyclonal antibody against amino terminus 
of Xenopus CPEB1; 2B7, monoclonal antibody against human CPEB1; pept, polyclonal antibody against amino-terminal peptide 
of Xenopus CPEB1 (see Materials and methods). (B) All three antibodies used detect recombinant CPEB1 in stage 24 embryos 
injected with CPEB1-RBM-GFP mRNA (Figure 3A). MO, morpholino. (C) UV cross-linking with 32P-labeled CPE-containing 
probe suggests the presence of non-CPEB1 CPE-binding proteins. Stage 41 eye extracts were incubated with 32P-UTP labeled 
probe consisting of the 3' end of Xenopus cyclin B1 with CPE motifs intact (lane 1) or mutated (lane 2), and resolved by SDS-
PAGE. Two bands are labeled with 32P (upper panel; indicated by arrows) but not detected by anti-CPEB1 western blot (lower 
panel). Proteins binding only to the mutated probe (lane 2) may recognize sequences masked by the CPE-binding proteins in 
the intact CPE-containing probe. Cross-linked samples were also subject to immunoprecipitation (IP) by control IgG (lane 3) or 
anti-CPEB1 antibody (lanes 4–5; pc, the polyclonal antibody labeled 'pc' in (A)). Anti-CPEB1 did not immunoprecipitate any 
cross-linked 32P-labeled CPE probe (lane 4). The bands at 70 kDa and 50 kDa on the western blot are most likely non-specific, 
as they do not correspond to any 32P signal. WB, western blot.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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strongly expressing AA/RFP-transfected neurons were seen
after electroporation of the brain by injection into the
ventricle (data not shown). Together, these results suggest
that while at least some RGCs expressing a substantial
amount of CPEB1-AA are able to make axons, they are
only short ones.
We next asked whether these effects of CPEB1-AA are spe-
cific to axon outgrowth or the result of more general
defects in cell survival or differentiation. Using DAPI
staining, transfected cells did not have pyknotic nuclei,
suggesting that CPEB1 overexpression did not simply
cause cell death (Figure 7B). In stage 41 sections of eyes
transfected with AA or RBM, cells in the central retina were
classified as photoreceptors, horizontal cells, bipolar cells,
amacrine cells, RGCs, or Müller cells based on their lami-
nar position and morphology [56,57]. No significant dif-
ferences were seen (Figure 7A); in particular, for all three
conditions, the percentage of cells in the RGC layer was
around 11–12%, consistent with the wild-type proportion
of RGCs [56].
To test whether CPEB1-transfected cells in the RGC layer
differentiate correctly, we determined the relative expres-
sion of Islet-1 (Isl-1), a homeodomain transcription factor
expressed in RGCs and some bipolar and amacrine cells
[58,59] that controls the expression of RGC-specific genes
and is required for RGC survival [60,61]. Of cells in the
RGC layer, approximately 50% of AA-transfected cells
expressed Isl-1, compared to 80% of RBM-transfected cells
(Figure 7C). This suggests that CPEB1-AA can affect RGC
differentiation, but only for some cells, perhaps depend-
ing on the stage in the cell's lifetime when CPEB1 overex-
pression began. Electroporated constructs are visibly
expressed around 6 hours after electroporation [55]; as
these embryos were electroporated at stage 28, transgene
expression should begin at stage 31. At this stage, future
RGCs may range from being in G1 before the final S
phase, through having axons nearly reaching the optic
chiasm [46,62], creating ample opportunity for variation
in the effects of CPEB1 on differentiation. Variability
could also stem from the amount of CPEB1 overexpres-
sion, but no obvious correlation between GFP expression
and Isl-1 expression level was observed. In any case, the
finding that 50% of AA-transfected RGCs still express Isl-
1 indicates that at least some RGCs differentiate and
should be able to send out axons, but their axons rarely
reach the optic chiasm and never enter the optic tract, sug-
gesting that at least some of CPEB1-AA's effects are specific
to axon outgrowth. Together, these results indicate that
CPE-mediated mRNA regulation is required for retinal
axon outgrowth.
Discussion
This study has shown that cytoplasmic polyadenylation is
required for growth cone collapse in response to Sema3A,
suggesting that cytoplasmic polyadenylation may regulate
guidance-cue-induced local translation. The mRNA of a
well-known regulator of cytoplasmic polyadenylation,
CPEB1, is present at low levels in RGCs, but CPEB1 pro-
tein is not detected in the retina, and knockdown of
CPEB1 function does not obviously affect retinal axon
guidance. However, UV cross-linking revealed the pres-
ence of other CPE-binding proteins in the retina, and
The CPEB1 mutant (S174A, S180A) (CPEB1-AA) disrupts  neurite outgrowth in vitro Figure 5
The CPEB1 mutant (S174A, S180A) (CPEB1-AA) 
disrupts neurite outgrowth in vitro. (A-C) Model for 
how CPEB1-AA competitively interferes with the function of 
endogenous cytoplasmic polyadenylation element (CPE)-
binding proteins. Normally, unidentified CPE-binding proteins 
regulate the translation or localization of CPE-containing 
mRNAs (A). The CEPB1-RNA binding mutant (C529A, 
C539A) (CPEB1-RBM), being unable to bind to CPE-contain-
ing RNAs, does not affect this situation and thus serves as a 
negative control (B). However, CPEB1-AA binds to the CPE, 
displacing native CPE-binding proteins, thus preventing CPE-
mediated mRNA regulation (C). (D) Fewer retinal cells 
transfected with CPEB1-AA-GFP (AA) have neurites com-
pared to cells transfected with CPEB1-RBM-GFP (RBM). (E) 
AA-expressing dissociated retinal neurons have shorter neu-
rites than those expressing RBM. Neurite length was quanti-
fied by digitally tracing the longest neurite of each transfected 
neuron (see Materials and methods for details). (F, G) Dis-
sociated retinal neurons transfected with RBM (F), or AA 
(G). Note the presence of CPEB1-GFP in the neurites. *p < 
0.05; ***p < 0.001. Scale bars: 15 μm. Error bars represent 
standard error of the mean.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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dominant-negative inhibition of CPE-binding in RGCs
causes axon outgrowth defects. These results indicate that
cytoplasmic polyadenylation and CPE-mediated regula-
tion of mRNAs are important for RGC axon development.
Cordycepin is a specific inhibitor for mRNA polyadenyla-
tion. Although it inhibits RNA synthesis [63], Sema3A-
induced growth cone collapse is known to be transcrip-
tion-independent [2]. Cordycepin can also inhibit deade-
nylation; an unidentified 3'-5' deadenylase in HeLa cell
extracts cannot act on mRNAs capped at the 3' end by a
cordycepin residue [64]. However, this is not an entirely
off-target effect, as it still addresses cytoplasmic control of
poly(A) tail length, and cordycepin could only affect this
deadenylase if it is added to the poly(A) tail by polyade-
nylation. The adenosine control argues against action by
cordycepin on adenosine receptors and rules out the pos-
sible inhibition of adenylate cyclase by cordycepin,
because adenosine and cordycepin inhibit adenylate
cyclase activity equally [65]. Finally, our finding that
cordycepin slightly reduces but does not abolish the
Sema3A-induced increase in translation suggests that
cordycepin leaves Sema3A signal transduction pathways
relatively intact. Consistent with this, cordycepin does not
inhibit Xenopus oocyte maturation induced by injection of
c-Mos, the synthesis of which occurs early in maturation
[40], implying that cordycepin does not affect kinases
downstream of c-Mos in oocyte maturation, such as
mitogen-activated protein kinase (MAPK) and p90Rsk
[66].
We have attempted to detect Sema3A-induced polyade-
nylation of candidate axonal mRNAs, such as RhoA [11],
which contains a CPE in the 3'UTR in Xenopus and is poly-
adenylated in maturing Xenopus  oocytes (data not
shown), but have been hampered by the extremely low
amounts of RNA obtainable from isolated Xenopus retinal
axons, which are not adequate to obtain reliable results
with existing PCR-based poly(A) tail assays [67,68]. In
addition, it is difficult to say a priori which mRNAs might
be polyadenylated, as only a handful of mRNAs are
known to undergo guidance cue-induced translation in
axons [5]. Nevertheless, our cordycepin results imply that
axonal mRNAs are polyadenylated in response to
Sema3A; future studies using more sensitive, unbiased
assays may identify these mRNAs.
The contrast between clear, though weak, detection of
CPEB1 mRNA in RGCs and the inability to detect CPEB1
protein in the retina suggests that CPEB1 protein might be
present at very low levels. Indeed, in one study, the CPEB1
remaining in oocytes after maturation-associated degrada-
tion was undetectable under normal loading and expo-
sure conditions, even though CPEB1 levels in mature
oocytes have been variously reported as 25% or 3–5% of
CPEB1 levels in immature oocytes [26,69]. Given that
CPEB1 was detected in oocytes in this study, we infer from
the amount of CPEB1 in oocytes [26] and the amounts of
protein loaded in our western blots (see Materials and
methods) that the inability to detect CPEB1 in retinas sug-
gests that the relative abundance of CPEB1 protein is
about 500 times lower in the retina than in oocytes. This
is not implausible, as CPEB1 mRNA levels are also much
higher in oocytes than in the embryonic retina (data not
shown), and in cDNA libraries collected from Xenopus
tropicalis, CPEB1 is an abundant clone in eggs (0.045% of
all clones, compared to 0.023% for ATP synthase, γ-subu-
nit) whereas it is not detected in cDNA libraries between
gastrulation and stage 45 [70].
Thus, the inability to detect CPEB1 protein leaves open
the possibility that RGCs contain a small amount of
CPEB1 protein. However, radiolabeled CPE-containing
RNA was bound by proteins that could not be detected by
anti-CPEB1 western blot or immunoprecipitation, sug-
gesting that even if a small amount of CPEB1 is present,
its function in regulating CPE-containing mRNAs may be
taken over by other proteins whose identities are
unknown. The other members of the CPEB family,
CPEB2–4, are expressed in embryonic eyes (Figure 2F),
and although they are not fully cloned in Xenopus laevis,
human CPEB2 has a predicted molecular weight of 62
kDa, suggesting that the approximately 60 kDa CPE-bind-
ing band could be CPEB2. CPEB2–4 have been reported
not to bind to one copy of CPE sequence (UUUUAAU)
[49], but this may not be true for all mRNAs if the CPE is
located in a loop structure. Future work on Xenopus CPEB2
awaits cloning of the gene and generation of an anti-
XCPEB2 antibody. In addition, KSRP (K-homology splic-
ing regulatory protein; known as VgRBP71 in Xenopus and
FUBP2, MARTA1, or ZBP2 in other species) binds CPE
sequences in mice (Y-SH and JDR, unpublished observa-
tions) and regulates the localization of β-actin mRNA in
neurons [71]. Although VgRBP71 is 71 kDa [72], its rat
homolog MARTA1 (molecular weight 74 kDa) was origi-
nally identified as a 90 kDa protein binding to the 3'UTR
of microtubule-associated protein 2 mRNA in UV cross-
linking assays [73,74], suggesting that the approximately
95 kDa CPE-binding band in Figure 4 could be VgRBP71.
Future studies may identify the CPE-binding proteins in
the Xenopus retina.
The effect of CPEB1-AA suggests that these non-CPEB1
CPE-binding proteins, or at least regulation of CPE-con-
taining mRNAs, are important for RGC axon develop-
ment. This regulation may occur via mRNA localization,
translational repression, translational activation, or all
three, as occurs with CPEB1 [18,30]. CPEB1-AA would
displace native CPE-binding proteins, thereby causing
mis-regulation of CPE-containing mRNAs (Figure 5A–C).Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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The CPEB1 mutant (S174A, S180A) (CPEB1-AA) disrupts axon outgrowth in vivo Figure 6
The CPEB1 mutant (S174A, S180A) (CPEB1-AA) disrupts axon outgrowth in vivo. (A) Retinal ganglion cells 
(RGCs) transfected with CPEB1-RBM-GFP (RBM) send axons to the optic tectum correctly. ch, optic chiasm. (B) Embryos 
where RGCs are transfected with CPEB1-AA-GFP (AA) do not have GFP-positive axons in the brain. (C) Schematic of bidirec-
tional plasmid encoding both GAP-red fluorescent protein (RFP) and CPEB1-green fluorescent protein (GFP). CMV, cytomeg-
alovirus; mPGK, mouse phosphoglycerate kinase. (D-G) Electroporation of bidirectional plasmids causes co-expression of 
GAP-RFP and CPEB1-GFP. Dashed boxes in (D) and (F) are shown at higher resolution in (E) and (G), respectively. (H) Dia-
gram of optic pathway in horizontal sections. Dashed boxes indicate the part of the pathway shown in (I), (J), and (K). (I) RFP/
RBM- and RFP/AA-transfected axons in the optic nerve head. These axons contain CPEB1-GFP (arrows). (J) Very rarely, an 
RFP/AA-transfected axon extends just beyond the optic chiasm. Dashed lines indicate expected path of retinal axons. (K) RFP/
RBM-transfected, but not RFP/AA-transfected, axons reach and branch in the tectum (arrowhead). The RFP/RBM image is a 
composite of two adjacent sections. (L) Number of RFP/RBM- and RFP/AA-transfected embryos with detectable RFP-positive 
axons reaching each intermediate target, analyzed in sections. (M-N) RFP/RBM-transfected embryos have bright RFP-positive 
axons in the optic pathway projecting correctly to the tectum, while RFP/AA-transfected embryos do not. Scale bars: 65 μm 
(A, B, M, N); 10 μm (D, F, J, K); 5 μm (I). Blue, DAPI; green, CPEB1-GFP; red, GAP-RFP. Dashed lines indicate inner and outer 
plexiform layers and solid lines indicate the apical and basal limits of the retina. Abbreviations: INL, inner nuclear layer; ONL, 
outer nuclear layer.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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Indeed, expression of dominant-negative CPEB1 in
Purkinje cells causes defects in cerebellar long-term
depression and motor learning, while elimination of
endogenous CPEB1 does not [33,35], suggesting that
non-CPEB1 CPE-binding proteins are also involved in
synaptic plasticity.
Our finding that CPE-mediated mRNA regulation is
important for axon outgrowth is consistent with other
studies demonstrating roles for post-transcriptional regu-
lation in axon formation and extension. For example, reg-
ulation of neurofilament-M mRNA by heterogeneous
nuclear ribonucleoprotein (hnRNP) K is required for axon
outgrowth in Xenopus [75], although hnRNP K is unlikely
to be a CPE-binding protein, as it binds to poly(C)
sequences [76]. In addition, translational regulation of
the neuronal polarity regulator SAD kinase (also known
as BR serine/threonine kinase 2 or brain-selective kinase
2) by the mammalian target of rapamycin (mTOR) path-
way controls axon formation [77]. It is likely that coordi-
nated regulation of many mRNAs by multiple RNA-
binding proteins is required for the complex program of
axon extension.
Given that axon extension and growth cone collapse are in
some ways opposite phenomena, the effect of dominant-
negative CPEB1 on axon extension seems opposed to the
requirement for cytoplasmic polyadenylation in growth
cone collapse. These can be reconciled by noting that the
CPE-binding proteins displaced by CPEB1-AA may not
necessarily regulate cytoplasmic polyadenylation, or may
regulate the polyadenylation of only a subset of mRNAs
that are polyadenylated upon Sema3A stimulation. It
would be interesting to directly test the connection
between cytoplasmic polyadenylation and the retinal
CPE-binding proteins by asking whether cordycepin
inhibits axon outgrowth as CPEB1-AA does, or if CPEB1-
AA inhibits growth cone collapse as cordycepin does.
However, the former experiment would be difficult to
interpret given the inhibition of transcription by cordyc-
epin over the timescales required to study neurite out-
growth, while the latter experiment is precluded by the
The CPEB1 mutant (S174A, S180A) (CPEB1-AA) reduces, but does not abolish, retinal ganglion cell (RGC) differentiation Figure 7
The CPEB1 mutant (S174A, S180A) (CPEB1-AA) reduces, but does not abolish, retinal ganglion cell (RGC) 
differentiation. (A) Cells transfected with CPEB1-GFP classified into the six retinal cell types according to layering and mor-
phology; no differences were observed. (B) Examples of cells in the RGC layer transfected with CPEB1-RBM-GFP (RBM) or 
CPEB1-AA-GFP (AA) that are positive for Isl-1 staining. Blue, DAPI; green, GFP; red, Isl-1. In each image, the upper and lower 
dotted lines indicate the outer and inner plexiform layers, respectively. The upper and lower solid lines indicate the apical and 
basal limits of the retina, respectively. Numbers in or above bars indicate number of cells counted. (C) Fewer cells in the RGC 
layer transfected with AA express Isl-1 compared to RGCs transfected with RBM. However, approximately half of AA-
expressing cells still express Isl-1. Scale bars 5 μm. Abbreviations: A, amacrine cell; BP, bipolar cell; GCL, ganglion cell layer; H, 
horizontal cell; INL, inner nuclear layer; M, Müller cell; ONL, outernuclear layer; PR, photoreceptor; RPE, retinal pigment epi-
thelium.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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lack of CPEB1-AA-positive axons growing out of trans-
fected retinal explants.
Even if CPE-binding proteins do indeed regulate cytoplas-
mic polyadenylation, the apparent contradiction
described above can be resolved by noting that axon
extension and Sema3A-induced collapse occur at different
time points of RGC axon development; the effect of
CPEB1-AA on axon outgrowth is observed early and most
likely includes an effect on neurite initiation (Figure 5D),
whereas Sema3A is more effective at collapsing old
growth cones (cultured after stage 35/36) than young
growth cones [37]. Thus, CPE-mediated mRNA regulation
and cytoplasmic polyadenylation may have different roles
at different developmental stages. Alternatively, just as
protein synthesis is required for both attractive and repul-
sive responses, CPE-mediated mRNA regulation and cyto-
plasmic polyadenylation may be involved in both
attractive and repulsive responses; future work may exam-
ine this possibility.
The conclusion that non-CPEB1 CPE-binding proteins,
which may or may not regulate cytoplasmic polyadenyla-
tion, are involved in RGC axon outgrowth leaves open the
question of how cytoplasmic polyadenylation is regu-
lated. It is not necessarily surprising that different mecha-
nisms would regulate cytoplasmic polyadenylation in
oocytes and embryos. For example, even though maternal
mRNAs are silenced in immature oocytes from stage I to
stage VI, PARN is not expressed until stage III [78,79], sug-
gesting that other mechanisms not involving PARN must
deadenylate and silence maternal mRNAs in early imma-
ture oocytes. In addition, in early Drosophila embryos, reg-
ulated translation of germ plasm mRNAs is correlated
with their poly(A) tail length, but seems to be independ-
ent of the Drosophila CPEB homolog ORB [80]. Similarly,
in Xenopus early embryogenesis, cytoplasmic polyadenyla-
tion of mRNAs such as activin receptor is mediated by U-
rich sequences (U12–27) similar to, but distinct from, the
CPE bound by CPEB1 (U4-6A1-2U) during oocyte matu-
ration [81-83]. These U-rich sequences are bound by ElrA
(elav-like ribonucleoprotein A) [84,85], suggesting that
ElrA mediates cytoplasmic polyadenylation, although this
has not been directly demonstrated. In addition, although
ElrA is unlikely to be one of the CPE-binding proteins in
Figure 4, as its molecular weight is 36 kDa and it does not
bind the cyclin B1 3'UTR, it can bind to the CPE bound by
CPEB1 (U4-6A1-2U) in some mRNAs such as cyclin E1
[85]. ElrA is expressed in Xenopus throughout develop-
ment [86], making it a potential regulator of some CPE-
containing mRNAs and cytoplasmic polyadenylation in
the retina.
In addition to ElrA, a role in regulation of the poly(A) tail
length of target mRNAs has been described for other pro-
teins, Musashi [24] and Pumilio [25], as well as the micro-
RNA let-7 [87]. Although Musashi (also known as nervous
system-specific RNP protein, or Nrp-1) is not expressed in
Xenopus  differentiated RGCs [88], we have detected
Pumilio and miRNAs in RGCs (F van Horck and M-L Bau-
det, unpublished observations). Pumilio and let-7 repress
target mRNAs by stimulating deadenylation, as CPEB1
does in immature oocytes. If these or other factors repress
and deadenylate mRNAs in unstimulated growth cones,
Sema3A stimulation might cause them to release their tar-
get mRNAs, allowing them to be polyadenylated by
default, which would explain why cordycepin prevents
Sema3A-induced collapse. Future studies may determine
whether these RNA-binding proteins, micro-RNAs, CPE-
binding proteins, or other mechanisms regulate cytoplas-
mic polyadenylation in RGC axons, aided by the identifi-
cation and 3'UTR sequence analysis of mRNAs that are
polyadenylated upon guidance cue stimulation.
Conclusion
Our results show for the first time that cytoplasmic polya-
denylation is required for growth cone chemotropic
responses. We have also shown that regulation of CPE-
containing mRNAs is involved in retinal axon outgrowth.
These results pave the way for future studies to investigate
the identity of the CPE-binding proteins in the Xenopus
retina and how cytoplasmic polyadenylation is regulated
in retinal axons.
Materials and methods
Embryos
Xenopus laevis embryos were obtained by in vitro fertiliza-
tion, raised in 0.1× Modified Barth's Saline at 14–20°C
and staged according to [89].
Cell culture
Eyes were dissected from stage 37/38 embryos and cul-
tured at 20°C for 24 h in 60% L-15 (Invitrogen; Paisley,
UK) on coverslips coated with 10 μg/ml poly-L-lysine and
10 μg/ml laminin (Sigma; Gillingham, UK). For dissoci-
ated culture, eyes were electroporated at stage 26–28 and
dissected at stage 32–33, cut in half, trypsinized for 2 min-
utes, dissociated in Ca2+-free medium with 1% bovine
serum albumin, and plated on coverslips coated with 100
μg/ml poly-L-lysine and 10 μg/ml laminin in 60% L-15
with 5% fetal bovine serum (Gibco). GFP-positive cells
were imaged at 100× on a Nikon TE2000-U microscope.
Cells with and without neurites were counted and for
those with neurites, the length of the longest neurite was
measured by tracing in Openlab (Improvision; Coventry,
UK) using a digital pen tablet (Wacom). A6 kidney epithe-
lial cells were thawed from a lab stock and grown in 60%
L15 medium with penicillin-streptomycin-fungizone
(PSF) and 5% serum.Neural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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Collapse assays
Stage 37/38 retinal explant cultures were pre-incubated
for 30 minutes with 200 μM cordycepin or 200 μM ade-
nosine (Sigma), then treated with the collapsing agent (2
μg/ml Sema3A-Fc (R&D Systems; Minneapolis, MN), con-
trol medium, 1 μM lysophosphatidic acid (Sigma)) for 10
minutes and fixed. For experiments on severed axons,
cordycepin or adenosine was applied immediately after
severing. Collapsed and non-collapsed growth cones were
counted in a blinded manner. A growth cone was counted
as collapsed if it had no lamellipodia and two or fewer
filopodia, each shorter than 10 μm.
Measurement of protein synthesis levels
3H-leucine incorporation assays were performed as
described [2]. For puromycin labeling, retinal cultures
were treated with cordycepin, adenosine, puromycin
(Sigma), LnLL (Sigma), anisomycin (Sigma), and/or
Sema3A-Fc as described in Figure 2F. After treatment, the
entire solution was removed and the cultures were lysed
in 50 μl RIPA buffer and subjected to SDS-PAGE and west-
ern blotting with anti-puromycin antibody.
Electroporation
Electroporation was performed as described [55]. Briefly,
anesthetized stage 28 embryos were placed in the longitu-
dinal channel of a t-shaped Sylgard chamber and flat-
ended 0.5 mm wide platinum electrodes (Sigma) were
placed in the ends of the transverse channels. Glass capil-
laries were filled with carboxyfluorescein-tagged antisense
MO (1 mM) or DNA (1–4 μg/μl in water). Approximately
10–30 nl of MO or DNA solution was injected into the
space between the eye and the brain. Injections stopped
and the capillary was removed immediately before the
first electric pulse was delivered by the square wave pulse
generator (TSS20 OVODYNE electroporator, Intracel;
Royston, UK). The pulse series consisted of 8 pulses, 18–
20 V, 25–50 ms long, 1s apart.
Imaging and analysis of transfected embryos
Embryos were fixed in 4% formaldehyde for 1–2 h at
room temperature. For wholemount preparations, the
brain was dissected out and split in half along the midline
to exclude brains with extra-retinal transfection. The two
half-brains were mounted lateral side up. For sections, 8–
25 μm horizontal cryosections were cut from embryos
equilibrated in 30% sucrose and embedded in Tissue-Tek
O.C.T. compound (Sakura Finetek; Zoeterwoude, the
Netherlands). Wholemounted brains and sections were
imaged at 20× and 40× on a Nikon Eclipse 80i upright
microscope, using constant video settings for quantitative
analysis of axon brightness. In cases where axons did not
lie in a single focal plane, a z-stack was taken and a com-
posite image was created using Openlab. The brightest ret-
inal axon in each sample was digitally traced in ImageJ,
and the average intensity along the axon was measured.
The background intensity to be subtracted from this value
was taken as the average intensity along a freehand line
drawn along both sides of the axon of interest, as close as
possible to the axon in an area free of other labeled axons.
Plasmids
GAP-RFP was subcloned by PCR using the primers 5'-
GAAGATCTATGCTGTGCTGTATGAGAAG-3' and 5'-
CGGCTAGCCTAGGCGCCGGTGGAGTGGC-3', digested
with NheI and BglII, and ligated into NheI/BglII-digested
mPGK-biCS2+ (gift of D Turner, University of Michigan).
To create the CPEB1(S174A, S180A)-GFP (CPEB1-AA-
GFP) fusion construct, the stop codon of full-length
CPEB1 was mutated to a cysteine by PCR amplification;
the PCR product was digested with HindIII and BglII and
the 370 bp DNA fragment was cloned into HindIII/
BamHI-digested pEGFP-N1 (Clontech; Mountain View,
CA). The resulting plasmid was digested with BglII and
HindIII and ligated with the 1.3 kb BglII and HindIII frag-
ment of CPEB1-AA excised from myc-CPEB1-AA [23].
CPEB1(C529A, C539A)-GFP (CPEB1-RBM-GFP) was cre-
ated previously [30]. CPEB1-AA-GFP and CPEB1-RBM-
GFP were subcloned by PCR using the primers 5'-
CGGAATTCATGGCCTTCCCACTGAAAGA-3' and 5'-
GCTCTAGATTACTTGTACAGCTCGTCCA-3' followed by
EcoRI/XbaI digestion and ligation into EcoRI/XbaI-
digested pCS2+ or mPGK-biCS2+-GAP-RFP. Gld 2(D24
2A)-GFP was created by replacing CPEB1-RBM with
Gld2(D242A) in pCS2+-CPEB1-RBM-GFP. Gld2(D242A)
was amplified by PCR from pMyc-Gld2(D242A) [22]
using the primers 5'-CGGAATTCATGTACCCTAACTC-
CCCCAG-3' and 5'-CGACCGGTCCTAACGAGTGCATTT
TTTTC-3', digested with EcoRI and AgeI, and ligated into
EcoRI/AgeI-digested pCS2+-CPEB1-RBM-GFP.
Wholemount in situ hybridization
Sense and antisense Dig-labeled riboprobes were tran-
scribed in vitro from the full-length sequence of Xenopus
CPEB1 in pBluescript. After quantification of Dig-incor-
poration to match sense and antisense probe concentra-
tions, wholemount in situ hybridization was carried out as
described [90].
Blastomere injection
Blastomere injection of MOs (10 ng/cell at two-cell stage)
and mRNA (1 ng) transcribed in vitro using the mMES-
SAGE mMACHINE kit (Ambion; Austin, TX) was per-
formed as described [91].
Laser capture microdissection
Stage 41 embryos were lightly fixed (4% formaldehyde,
5–10 minutes) and 8 μm horizontal cryosections wereNeural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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collected on a PEN-membrane slide (Leica Microsystems;
Wetzlar, Germany). The RGC layer was microdissected
out of these sections using a Leica LMD6000 laser micro-
dissection system and collected in 20 μl lysis buffer.
RT-PCR
RNA was extracted using Qiagen RNeasy kits and RT-PCR
was performed using theOneStep RT-PCR kit (Qiagen;
Crawley, UK). Primers were as shown in Table 1.
DiI filling
DiI filling was performed essentially as described [92,93].
E17–E19 CPEB1 +/- and CPEB1 -/- mouse embryos were
fixed in 4% formaldehyde. Small crystals of 1,1'-dioacta-
decyl-3, 3, 3', 3'-tetramethylindocarbocyanin perchlorate
(DiI; Invitrogen) were inserted into the optic disc using
fine forceps. Embryos were incubated in 4% formalde-
hyde for 6–10 weeks at 32°C. Labeled brains were imaged
on a Leica MZFLIII epifluorescence microscope. For Xeno-
pus embryos, a solution of DiI crystals dissolved in chlo-
roform (Sigma) was loaded into a glass capillary. The lens
was removed and the DiI solution was injected into the
eye, ensuring that the DiI droplet that formed contacted
the optic fiber layer. Embryos were incubated at room
temperature for 2 days before dissection.
Immunofluorescence
Wholemount
Fixed mouse retinas were dissected from E17–E19 wild-
type, CPEB1 +/- and CPEB1 -/- embryos, and the lenses
were removed. Retinas were washed 3 × 10 minutes and 1
× 30 minutes in PBT (1× phosphate-buffered saline (PBS),
0.2% bovine serum albumin, 0.5% Triton), blocked for
60 minutes in PBT + 10% heat-inactivated goat serum,
incubated in primary antibody in blocking buffer over-
night at 4°C, washed for 2 × 10 minutes and 3 × 30 min-
utes in PBT, incubated in Cy3-conjugated anti-mouse
antibody in blocking buffer for 1 h, washed 5 × 20 min-
utes in PBT, and flattened and mounted.
Sections
Sections were air-dried and OCT was removed by 2 × 5
minutes washes in 1× PBS. For Isl-1 staining, slides were
pre-treated with 0.01 M sodium citrate, pH 6.0 at 95°C for
10 minutes to expose the Isl-1 epitope. Slides were
washed 3 × 5 minutes in PBT (1× PBS + 0.01% Triton X-
100), blocked 20 minutes in PBT + 10% HIGS, incubated
with primary antibody for 1 h, washed 3 × 5 minutes with
PBT, incubated with secondary antibody for 45 minutes,
followed by DAPI (4',6-diamidino-2-phenylindole; 50
ng/ml in PBT) for 10 minutes and 3 × 5 minute washes
with PBT, and mounted in FluoroSave. fluorescein isothi-
ocyanate (FITC)-conjugated goat anti-GFP (1:500;
Abcam; Cambridge, UK) was used on heated slides to
recover GFP signal.
Western blots
Samples were lysed in RIPA buffer (Sigma) with a protease
inhibitor cocktail (Sigma) on ice for 30 minutes, homog-
enized and centrifuged, and the supernatant was taken
and boiled in sample buffer for 5 minutes. The lysate of
approximately 10 eyes or 0.5 oocytes was loaded on each
lane. Samples were run through a 4% stacking gel at 50 V
and an 8–12% resolving polyacrylamide gel at 50–150 V,
then transferred onto a nitrocellulose membrane at 4°C
and 40 mA overnight. Membranes were blocked for 1–2 h
in TBST (5 mM Tris pH 8.0, 150 mM NaCl, 0.05% Tween-
20) with 5% dry milk, incubated in primary antibody for
1–2 h at room temperature or overnight at 4°C in TBST
with 0.5% milk, washed twice in TBST without milk for 15
minutes each, incubated in secondary antibody conju-
gated to horseradish peroxidase (HRP) in TBST with 0.5%
Table 1: Primers used for RT-PCR
Name Sequence (5'-3') GenBank accession number of gene
xGld2 f TGACCACATAGACACCACTTTGCC AY655140
xGld2 r CGCACCACTGACTTTATCCCTG
Symplekin f GCTATCTCCAGCATCAACCTTACG BC047265
Symplekin r TGTCCCCCTTCACCATCTTCTC
PARN f AACACATCCCTTGCCGAACTG 14495248
PARN r GGTAGAGGTCACTGGTCTTCCATTC
CPEB1 f GCAACTTTGTGCGTAGTCCA NM_001090603
CPEB1 r TCCATAGAGTGCTGCCAGTG
CPEB2 f CCATCAAAGCAGTGGTTGGAAC BX850448
CPEB2 r GAACGAGTGAACTTGGGTGGTG
CPEB3 f CAGTCAGTTTGTGGTAAGCAGTCG BJ617668
CPEB3 r ATGGGGACAGAGATGGGGTG
CPEB4 f CAAAGTCCATCACCAACACCCTC CF547305
CPEB4 r CCATCATCCAGAAATCCATCTTCC
β-actin f CCTGTGCAGGAAGATCACAT BC041203
β-actin r TGTTAAAGAGAATGAGCCCCNeural Development 2009, 4:8 http://www.neuraldevelopment.com/content/4/1/8
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milk for 45 minutes at room temperature, and washed 3
times in TBST for 15 minutes each. HRP was detected with
ECL Plus (GE Healthcare; Chalfont St. Giles, UK) and X-
ray film (Kodak).
UV cross-linking and immunoprecipitation
UV cross-linking was performed as described [54]. Briefly,
the 3'UTR of Xenopus cyclin B1 mRNA containing or lack-
ing two CPE sequences [94] was transcribed in vitro with
32P-UTP and purified on a DyeEx column. Stage 41 eyes
were lysed in immunoprecipitation buffer (25 mM HEPES
pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, 2 mM
EDTA, 1 mM MgCl2, 0.5% Triton X-100, 2 mM sodium
orthovanadate, 2 mM beta-glycerophosphate, and pro-
tease inhibitor cocktail (Roche Applied Science; Indianap-
olis, IN). Eye lysate was incubated with the radiolabeled
RNA probe (2.6 × 105 cpm) for 10 minutes on ice and 10
minutes at room temperature followed by UV cross-link-
ing (440 mJ; UV Stratalinker 1800) and RNase A digestion
of unprotected RNA. Cross-linked samples were pre-
cleared with IgG-conjugated sepharose beads and incu-
bated with 2 μl rabbit IgG or anti-CPEB1 antibody and 30
μl protein A-sepharose beads overnight at 4°C, and
washed 5 times in immunoprecipitation buffer (0.05%
Triton instead of 0.5%). Input and immunoprecipitated
samples were boiled in sample buffer, run on 10% SDS-
PAGE, transferred to a PVDF membrane, and autoradio-
graphed. The membrane was then subjected to western
blot with anti-CPEB1.
Reagents and antibodies
Cordycepin and adenosine were dissolved in culture
medium to a stock concentration of 4 mM and stored at -
20°C. Recombinant human Sema3A-Fc chimera (R&D
Systems) was reconstituted in 0.1% protease-free bovine
serum albumin (Sigma) in 1× PBS, aliquoted, and stored
at -80°C. The carboxyfluorescein-tagged anti-CPEB1 MO
was 5'-ATCATCTTTCAGTGGGAAGGCCATG-3' (Gene
Tools; Philomath, OR). Anti-CPEB1 antibodies were: the
2B7 mouse monoclonal antibody against human CPEB1,
1:1000 ('2B7') [95]; a rabbit antibody against two Xenopus
CPEB1 peptides, 1:12,000 ('peptide') [69]; and a rabbit
antibody against the amino terminus of Xenopus CPEB1
('pc'). Other primary antibodies were: mouse anti-β-tubu-
lin, 1:100 (E7, DSHB; Iowa City, IA); mouse anti-Isl-1,
1:100 (39.4D5, DSHB); mouse anti-myc, 1:100 (9E10,
DSHB); FITC-tagged goat anti-GFP for immunofluores-
cence, 1:500 (Abcam); mouse anti-GFP for western blot-
ting, 1:1,000 (Roche); rabbit anti-puromycin, 1:500
(custom-made antiserum from Eurogentec; Fawley, UK);
mouse anti-β-actin, 1:1000 (AC15, Abcam); mouse anti-
Symplekin, 1:200 (immunofluorescence) and 1:2000
(western blot) (BD Biosciences; Franklin Lakes, NJ); rab-
bit anti-PARN, 1:2,000 (gift of M Wormington); rabbit
anti-Gld2, 1:500 [19]. Secondary antibodies were: Alexa
594-conjugated donkey anti-rabbit, 1:1,500 (Molecular
Probes); Cy3-conjugated goat anti-mouse 1:700 (Calbio-
chem; San Diego, CA); HRP-conjugated goat anti-mouse,
1:5,000–10,000 (Abcam); HRP-conjugated goat anti-rab-
bit 1:20,000 (Zymed).
Abbreviations
AA: CPEB1-AA-GFP; CPE: cytoplasmic polyadenylation
element [consensus (U)4–5(A)1-2U]; CPEB: CPE-binding
protein; CPEB1-AA: CPEB1 mutant (S174A, S180A);
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2; Isl-1: Islet-1; MO: morpholino; PARN: poly(A) ribonu-
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Gld2, PARN, and Symplekin are expressed in the retina, mainly in the 
nucleus. (A, B) Gld2, PARN, and Symplekin are detected in Xenopus 
embryonic eyes by RT-PCR (A)and western blot (B). (C-E) Sections of 
stage 41 eyes electroporated with Gld2(D242A)-GFP. Gld2(D242A)-
GFP is mainly localized in the nucleus (arrows) but can sometimes be 
cytoplasmic in photoreceptors (D, arrowhead), with some faint cytoplas-
mic signal also seen in some RGCs (E, arrowhead). Green, Gld2-GFP; 
blue, DAPI. (F, G) Sections of stage 41 eyes electroporated with myc-
PARN(D28A), which is also localized to the nucleus in most cells 
(arrows), with occasional cytoplasmic localization in photoreceptors 
(arrowhead). Red, myc-PARN; blue, DAPI. (H-J) Immunohistochemis-
try on sections of stage 41 Xenopus eye with anti-Symplekin antibody 
reveals nuclear localization of endogenous Symplekin. (H) DAPI, (I) 
Symplekin, (J) merge. Note that Symplekin is not expressed at the ciliary 
margin (arrows). Red, Symplekin; blue, DAPI. Scale bars: 10  m (C-E); 
5  m (F, G); 30  m (J). In (C-E), the upper and lower dashed lines indi-
cate the outer and inner plexiform layers, respectively, while the upper and 
lower solid lines indicate the retinal pigment epithelium and optic fiber 
layer, respectively.
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